4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-109942
Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)
- Interim CEO & General Counsel acquired 20,835 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Vogt Frederick G · Interim CEO & General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-16 | Exercise or conversion : show line 1 in the form | +20,835 | 93,685 | D | ||
| 2023-10-16 | Shares withheld for taxes : show line 2 in the form | −8,851 | $3.57 | $31,598 | 84,834 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-16 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −20,835 | 104,172 | D |
Loading xslF345X05/tm2328751-3_4seq1.xml…